Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

Thierry André, Kai‐Keen Shiu, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Cornelis J.A. Punt, Denis Smith, Rocio García‐Carbonero, Manuel Benavides, Peter Gibbs, Christelle de la Fouchardière, Fernando Rivera, Élena Elez, Johanna C. Bendell, Dung T. Le, Takayuki Yoshino, Eric Van Cutsem, Ping Yang, Mohammed Z.H. Farooqui, Patricia Marinello, Luis A. Díaz

New England Journal of Medicine, 2020

Gentofte Hospital, Sorbonne Université, Hôpital Saint-Antoine, University College Hospital, University College London, Asan Medical Center, University of Ulsan, Region of Southern Denmark, Amsterdam University Medical Centers, University of Amsterdam, Bordeaux Population Health, Hospital Universitario 12 De Octubre, Hospital Regional Universitario de Málaga, Western Health, Centre Léon Bérard, Marqués de Valdecilla University Hospital, Vall d'Hebron Institute of Oncology, Sarah Cannon, Tennessee Oncology, Sidney Kimmel Comprehensive Cancer Center, National Cancer Center Hospital East, Universitair Ziekenhuis Leuven, KU Leuven, Merck & Co., Inc., Rahway, NJ, USA (United States), Memorial Sloan Kettering Cancer Center

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

2837

Citations

View on Google Scholar

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

Abstract

Journal Details

Join JournalsHub

Welcome Back